Key Market Indicators
Chilean sales of digestive system disorder medicines are set to reach $812 million by 2026. In 2021, sales were $681.6 million – an increase of 5% annually since 2005. Chile was ranked 12th in 2021. Portugal was first with $681.6 million. Japan, South Korea and Canada were 2nd, 3rd and 4th respectively.